Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants

This clinical trial evaluates the postprandial glycaemic response to an Oral Nutritional Supplement (ONS), a Food for Special Medical Purposes (FSMP), in healthy adults. The study uses a crossover design comparing the ONS to the reference product glucose. Each participant will consume both test and reference products on three separate occasions each, overall on six test days.

Participants needed: 30
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Fresenius KabiUpdated: Mar 23, 2026
Eligibility criteria

Aged ≥18 and ≤60 years, adult healthy Caucasian or Chinese participants [+2]

Pregnant or lactating, [+5]

Read more
Status: Recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of parenteral nutrition treatment with SMOFlipid.

Participants needed: 100
Trial details
Phase: Phase 4Age: 1-17Biological sex: AllType: InterventionalSponsor: Fresenius KabiUpdated: Dec 4, 2025Locations: 5
Eligibility criteria

Male or female patients, at least 1 month of age. [+3]

Use of any other lipid injectable emulsion than SMOFlipid within 6 months prior... [+16]

Read more
Status: Recruiting

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source of calories and fatty acids in this patient population

Participants needed: 40
Trial details
Age: 1-17Biological sex: AllType: ObservationalSponsor: Fresenius KabiUpdated: Sep 5, 2025Locations: 10
Eligibility criteria

Patient's parent(s) or legal guardian(s) has provided a signed and dated Informe... [+2]

Patient has received Omegaven within four weeks before inclusion in the study [+15]

Read more